Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-25 @ 2:56 AM
NCT ID:
NCT01871233
Eligibility Criteria:
Inclusion Criteria:
* Patients who are participating in either Study 207, Study 307, or Study 235 and who in the opinion of the treating physician, continue to benefit from treatment with perampanel (revised per Amendment 01)
* Patients who provide informed consent where applicable per local requirements.
* Female patients of childbearing potential must agree for the duration of the program and for a period of at least 1 month following last dose of perampanel to be abstinent or to commit to the consistent and correct use of a medically acceptable method of birth control (e.g., a double-barrier method \[condom plus spermicide, condom plus diaphragm with spermicide\])
Exclusion Criteria:
* Patients residing in countries where perampanel is commercially available for the treatment of POS
* Female patients who are lactating, pregnant, or planning to become pregnant
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
70 Years
Study:
NCT01871233
Study Brief:
Protocol Section:
NCT01871233